Stephen R. Brady, EVP, Strategy & Finance at Immune Design Corp. (IMDZ), bought 1,500 shares at $6.84 ($10K) on 2016-07-15, disclosed to the SEC on 2016-07-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| IMDZ | SELL | 2018-01-08 | $14K | — | Filing → |
| IMDZ | SELL | 2017-01-06 | $9K | — | Filing → |